Leaderboard

En | De
Sie sind hier: Gastroenterologie » Pankreas » Neoplasie 16. Juni 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gallenwege
Leber
Magen-Darm
Oesophagus
Pankreas
Neoplasie
Pankreatitis
Anderes
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 3023  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 60441  
   
TIPE3 in Cancer: A Multifaceted Regulator of Tumorigenesis, Therapeutic Resistance, and Clinical Outcomes.
Technol Cancer Res Treat
Zhang Y, Cao H, Yu D, Feng W, Cao S, Zhou Y, Lau KS, Li Z.
PMID: 42299458 [PubMed - indexed for MEDLINE]


Pancreatic Cancer Early Detection Biomarkers for High-Risk Individuals: Insights From the PRECEDE Consortium.
Int J Cancer
Worthington C, Raitses-Gurevich M, Innamorati G, Hart PA, Wilkie TM, Tau N, Brin D, Yablecovitch D, Laish I, Keith D, Giles K, Permuth JB, Simeone DM, Zogopoulos G, Brand RE, Graff JJ, Earl J, PRECEDE Consortium.
PMID: 42298760 [PubMed - as supplied by publisher]


ASO Visual Abstract: Benefit of Adjuvant Therapy after Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis.
Ann Surg Oncol
Frey MC, Lopez-Lopez V, Benz A, Abdurakhmonov S, Amirian H, Datta J, Lee SH, Yoo C, Pu N, Zhang C, Reames BN, Fritsch R, Petrowsky H, Oberholzer J, Eshmuminov D.
PMID: 42298078 [PubMed - as supplied by publisher]


Semaglutide and Risk of Pancreatic Cancer: A Meta-Analysis of Randomised Trials.
Diabetes Obes Metab
Chiang CH, Bahar F, Chang YC, Wang TH, Hsia YP, Chiang CH.
PMID: 42297743 [PubMed - as supplied by publisher]


Risk of pancreatic cancer associated with precursor lesions in individuals and first-degree relatives: a nationwide cohort study.
Clin Gastroenterol Hepatol
Ludvigsson JF, Sun J, Yuan C, Vujasinovic M, Löhr JM, Wolpin BM, Wang QL.
PMID: 42297317 [PubMed - as supplied by publisher]


Phase II Trial of First-Line Durvalumab and Chemotherapy in Patients With Extra-Pulmonary Small Cell Carcinoma.
JTO Clin Res Rep
Kok PS, Chan B, Aberoumoud M, Zhang A, O'Byrne K, Thavaneswaran S, Lin F, Kansara M, Corpuz T, Wheeler P, Simes RJ, Thomas D, Lee CK.
PMID: 42293288 [PubMed]


LncRNA MIR22HG and miR-10a-5p: Pioneering serum biomarkers for pancreatic cancer diagnosis and progression assessment.
Noncoding RNA Res
Salman RM, Radwan AF, Shaker OG, El-Husseiny AA.
PMID: 42293029 [PubMed]


Study of JCAD for prognosis and immune infiltration in hepatocellular carcinoma.
Front Immunol
Wang Z, Tang J, Zhu S, Li S, Yao B, Tu J, Zhou X, Tang Q, Zhong L.
PMID: 42292467 [PubMed - indexed for MEDLINE]


The life cycle of tertiary lymphoid structures in pancreatic cancer-a window of opportunity for immunotherapy.
Front Immunol
Chen Y, Xiao Y, Zhang T, Wang X.
PMID: 42292349 [PubMed - indexed for MEDLINE]


Nimotuzumab combined with gemcitabine and nab-paclitaxel as first-line therapy for advanced pancreatic cancer: a single-arm, single-center Phase II prospective study.
Front Med (Lausanne)
Lin L, Zhao X, Luo Y, Cai JH, Lin Z, Xiao L, Tian G, He S.
PMID: 42292240 [PubMed]


Tumor infiltrating B cells and tertiary lymphoid structures in pancreatic cancer prognosis and therapy.
iScience
Pan Z, Zhang F, Zhang C, Li X, Ma Y, Yang Y, Tian X.
PMID: 42291273 [PubMed]


Natural Products and Long Noncoding RNAs: A Complex Regulatory Network in Pancreatic Cancer Progression and Treatment.
J Biochem Mol Toxicol
Elimam H, Radwan AF, Elfar N, Ghaiad HR, Abd-Elmawla MA, Zaki MB, Nassar K, Mohammed OA, Doghish AS.
PMID: 42290329 [PubMed - indexed for MEDLINE]


Central Pancreatectomy with Duct-to-Mucosa Pancreaticogastrostomy Using a Knotless Continuous Suturing Technique: Initial Experience with a Totally Laparoscopic Approach.
Asian J Endosc Surg
Kawashima M, Matsushita A, Hamaguchi A, Kato Y, Ono T, Irie T, Ga R, Aoki Y, Oshiro Y, Nakamura Y.
PMID: 42289762 [PubMed - indexed for MEDLINE]


Study on the inhibition of liver cancer progression by lenvatinib nanoparticles combined with hyaluronic acid/gelatin scaffold.
Colloids Surf B Biointerfaces
Zhu L, Chen H, Guo Q, Ren C, Shi P, Wang Q, Hu Y, Fan Z, Xu Y, Lin D, Chen H.
PMID: 42287829 [PubMed - as supplied by publisher]


6-mm versus 10-mm covered self-expandable metal stents and plastic stents for malignant distal biliary obstruction in resectable or borderline resectable pancreatic cancer in Japan (STARDOM, JON-2402P): study protocol for a multicenter randomized controlled trial.
Trials
Yamashige D, Hijioka S, Yasuda I, Hayashi N, Taguri M, Ueno M, Furuse J, Japan Oncology Network in Hepatobiliary and Pancreas.
PMID: 42286634 [PubMed - as supplied by publisher]


Intraductal Papillary Mucinous Neoplasm Worsening Glycemic Control in a Patient with Type 2 Diabetes Mellitus.
Am J Med Sci
Varghese RT, Ayar UD, Zamin MR, Oyalade FK, Valencia VC, Aoun ML.
PMID: 42285223 [PubMed - as supplied by publisher]


Health-related quality of life among patients with colorectal und pancreatic cancer: results from a monocentric registry study.
Gesundheitswesen
Piontek D, Schoffer O, Datzmann T, Boehme H, Distler M, Fritzmann J, Hempel S, Oehme F, Radulova-Mauersberger O, Ubbelohde U, Bornhaeuser M, Weitz J, Schmitt J.
PMID: 42285169 [PubMed - as supplied by publisher]


Clinicopathological features of pancreatic solid pseudopapillary neoplasm: A retrospective single-center study of 32 cases in Guangzhou, China.
Pathol Res Pract
Quan S, Li G, Liu S, Wu J, He P, Hu J.
PMID: 42284974 [PubMed - as supplied by publisher]


Mutant KRAS-driven selective mRNA translation reveals mechanisms and therapeutic vulnerabilities in cancer.
Cell Rep
Shrivastava A, Pederson EN, Nguyen TU, Chuen J, Mohan P, Pande S, Toribio AR, Lecomte N, Melchor J, McAuliffe JC, Grandgenett PM, Rajasekhar VK, Nishikawa K, Knörlein A, David Y, Willis IM, Iacobuzio-Donahue CA, Ouyang Z, Singh K.
PMID: 42284146 [PubMed - as supplied by publisher]


CLEC4G Promotes Pancreatic Cancer Progression by Suppressing Cathepsin B-Mediated Ferroptosis: Evidence From Mendelian Randomization Study and Experimental Validation.
Hum Mutat
Jiang Z, Ma P, Zhang S, Jin Z, Wang Y, Zhou Y, Zhu Q, Lu C, Tu N, Zhang ZA, Mou Y, Jin W.
PMID: 42282992 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 60441    Seite 1 von 3023  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1